WPI 2265 (Acitretin 22.5 mg)
Pill with imprint WPI 2265 is Brown, Capsule-shape and has been identified as Acitretin 22.5 mg. It is supplied by Actavis Pharma, Inc.
Acitretin is used in the treatment of psoriasis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 22.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2265
Acitretin
- Imprint
- WPI 2265
- Strength
- 22.5 mg
- Color
- Brown
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antipsoriatics
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-2265
- Inactive Ingredients
-
maltodextrin,
sodium ascorbate,
microcrystalline cellulose,
gelatin,
ferric oxide red,
shellac,
ferrosoferric oxide,
propylene glycol
Note: Inactive ingredients may vary.
More about acitretin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (36)
- Drug images
- Pricing & coupons
- En español
- Drug class: antipsoriatics
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.